Table 2.
Clinical characteristics of patients with Parkinson disease.
| No | Age (years) | Sex | Clinical diagnosis | Symptoms at onset | Illness duration (years) | Drug | Hoehn–Yahr score |
|---|---|---|---|---|---|---|---|
| 1 | 68 | M | PD | Tremor | 3 | D, AC, DA | III |
| 2 | 63 | M | PD | Hand tremor | 21 | D, M, DA | IV |
| 3 | 75 | F | PD | Hand tremor, gait disturbance | 11 | D, DA, AM | IV |
| 4 | 66 | F | PD | Gait disturbance, dysarthria | 13 | D, DA | III |
| 5 | 75 | F | PD | Tremor, gait disturbance | 31 | D. DA. AM, AC | IV |
| 6 | 81 | F | PD | Gait disturbance | 5 | D | V |
| 7 | 68 | F | PD | Tremor | 8 | D, AC, AM, DA, M | III |
| 8 | 65 | F | PD | Hand Tremor | 8 | D, DA | III |
| 9 | 72 | F | PD | Gait disturbance | 5 | D, DA, AC, AM | IV |
| 10 | 78 | F | PD-D | Gait disturbance, dysarthria | 2 | D | III |
PD, Parkinson disease; PD-D, PD with dementia; D, L-DOPA/carbidopa or benserazide; DA, dopamine agonists; A, anticholinergic; AM, amantadine; M, selegiline.